PT  - JOURNAL ARTICLE
AU  - Aurélie Mousnier
AU  - Hervé Leh
AU  - Jean-François Mouscadet
AU  - Catherine Dargemont
TI  - Nuclear Import of HIV-1 Integrase Is Inhibited in Vitro by Styrylquinoline Derivatives
AID  - 10.1124/mol.104.001735
DP  - 2004 Oct 01
TA  - Molecular Pharmacology
PG  - 783--788
VI  - 66
IP  - 4
4099  - http://molpharm.aspetjournals.org/content/66/4/783.short
4100  - http://molpharm.aspetjournals.org/content/66/4/783.full
SO  - Mol Pharmacol2004 Oct 01; 66
AB  - Nuclear import of HIV-1 preintegration complexes (PICs) allows the virus to infect nondividing cells. Integrase (IN), the PIC-associated viral enzyme responsible for the integration of the viral genome into the host cell DNA, displays karyophilic properties and has been proposed to participate to the nuclear import of the PIC. Styrylquinolines (SQs) have been shown to block viral replication at nontoxic concentrations and to inhibit IN 3′-processing activity in vitro by competing with the DNA substrate binding. However, several lines of evidence suggested that SQs could have a postentry, preintegrative antiviral effect in infected cells. To gain new insights on the mechanism of their antiviral activity, SQs were assayed for their ability to affect nuclear import of HIV-1 IN and compared with the effect of a specific strand transfer inhibitor. Using an in vitro transport assay, we have previously shown that IN import is a saturable mechanism, thus showing that a limiting cellular factor is involved in this process. We now demonstrate that SQs specifically and efficiently inhibit in vitro nuclear import of IN without affecting other import pathways, whereas a specific strand transfer inhibitor does not affect IN import. These data suggest that SQs not only inhibit IN-DNA interaction but would also inhibit the interaction between IN and the cellular factor required for its nuclear import.